Timing is everything: study seeks best interval for pregnancy loss medication
NCT ID NCT07506512
First seen Apr 08, 2026 · Last updated Apr 30, 2026 · Updated 4 times
Summary
This study aims to find the best time gap between taking two medications (mifepristone and misoprostol) to manage early pregnancy loss. About 1,000 participants will choose their own time interval, and researchers will track how well the treatment works, side effects, and patient satisfaction. The goal is to improve care and reduce the need for additional procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY PREGNANCY LOSS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.